Great Novel Therapeutics Biotech & Medicals reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was TWD 0.54 million. Net loss was TWD 39.65 million.
Great Novel Therapeutics Biotech & Medicals
Equities
7427
TW0007427007
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55 TWD | 0.00% | -3.51% | -17.66% |
1st Jan change | Capi. | |
---|---|---|
-17.66% | 65.56M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- 7427 Stock
- News Great Novel Therapeutics Biotech & Medicals
- Great Novel Therapeutics Biotech & Medicals Reports Earnings Results for the Nine Months Ended September 30, 2022